JP2013515698A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013515698A5 JP2013515698A5 JP2012545331A JP2012545331A JP2013515698A5 JP 2013515698 A5 JP2013515698 A5 JP 2013515698A5 JP 2012545331 A JP2012545331 A JP 2012545331A JP 2012545331 A JP2012545331 A JP 2012545331A JP 2013515698 A5 JP2013515698 A5 JP 2013515698A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- compound
- group
- methyl
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09382302 | 2009-12-23 | ||
| EP09382302.9 | 2009-12-23 | ||
| US30757910P | 2010-02-24 | 2010-02-24 | |
| US61/307,579 | 2010-02-24 | ||
| PCT/EP2010/070562 WO2011076878A1 (en) | 2009-12-23 | 2010-12-22 | Aminoalkylpyrimidine derivatives as histamine h4 receptor antagonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013515698A JP2013515698A (ja) | 2013-05-09 |
| JP2013515698A5 true JP2013515698A5 (enExample) | 2014-02-20 |
| JP5781537B2 JP5781537B2 (ja) | 2015-09-24 |
Family
ID=41667549
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012545331A Expired - Fee Related JP5781537B2 (ja) | 2009-12-23 | 2010-12-22 | ヒスタミンｈ４受容体アンタゴニストとしてのアミノアルキルピリミジン誘導体 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US8901146B2 (enExample) |
| EP (1) | EP2516420B8 (enExample) |
| JP (1) | JP5781537B2 (enExample) |
| KR (1) | KR101740085B1 (enExample) |
| CN (1) | CN102803248B (enExample) |
| AR (1) | AR079725A1 (enExample) |
| AU (1) | AU2010334804B2 (enExample) |
| BR (1) | BR112012017126A2 (enExample) |
| CA (1) | CA2785353C (enExample) |
| IL (1) | IL220554A (enExample) |
| MX (1) | MX345142B (enExample) |
| NZ (1) | NZ601021A (enExample) |
| PE (1) | PE20121505A1 (enExample) |
| RU (1) | RU2573828C2 (enExample) |
| TW (1) | TWI487697B (enExample) |
| UA (1) | UA107818C2 (enExample) |
| WO (1) | WO2011076878A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2493895T1 (sl) | 2009-10-29 | 2017-10-30 | Vectura Limited | Derivati heteroarila, ki vsebujejo N, kot inhibitorji JAK3 kinaze |
| UA121539C2 (uk) * | 2011-09-02 | 2020-06-25 | Інсайт Холдинґс Корпорейшн | Гетероцикліламіни як інгібітори рі3к |
| ES2946551T3 (es) | 2017-10-17 | 2023-07-20 | Palau Pharma S L U | Síntesis de compuestos de 4-aminopirimidina |
| GB201817047D0 (en) | 2018-10-19 | 2018-12-05 | Heptares Therapeutics Ltd | H4 antagonist compounds |
| JP2022165429A (ja) * | 2019-10-02 | 2022-11-01 | Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 | ヒスタミンｈ４受容体調節作用を有する新規トリアジン誘導体 |
| CN117018194B (zh) * | 2023-07-26 | 2026-04-17 | 同济大学 | 毒蕈碱型受体5型受体拮抗剂的用途 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR200001256T2 (tr) * | 1997-11-04 | 2000-11-21 | Pfizer Products Inc. | Terapötik olarak aktif bileşimler. |
| US7737153B2 (en) * | 2002-10-28 | 2010-06-15 | Bayer Schering Pharma Aktiengesellschaft | Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors |
| JP4544999B2 (ja) * | 2002-11-25 | 2010-09-15 | 持田製薬株式会社 | ４−ヒドロキシピペリジン誘導体を有効成分とする呼吸器疾患治療剤 |
| EP1505064A1 (en) * | 2003-08-05 | 2005-02-09 | Bayer HealthCare AG | 2-Aminopyrimidine derivatives |
| WO2005054239A1 (en) | 2003-12-05 | 2005-06-16 | Bayer Healthcare Ag | 2-aminopyrimidine derivatives |
| KR20080004585A (ko) * | 2005-04-08 | 2008-01-09 | 바이엘 파마슈티칼스 코포레이션 | 피리미딘 유도체 및 암의 치료에서의 이의 용도 |
| BRPI0615880A2 (pt) | 2005-09-13 | 2011-05-31 | Palau Pharma Sa | compostos derivados de 2-aminopirimidina como moduladores da atividade de receptor da histamina h4, uso dos mesmos e composição farmacêutica |
| US7528143B2 (en) * | 2005-11-01 | 2009-05-05 | Targegen, Inc. | Bi-aryl meta-pyrimidine inhibitors of kinases |
| NL2000323C2 (nl) | 2005-12-20 | 2007-11-20 | Pfizer Ltd | Pyrimidine-derivaten. |
| US20100035863A1 (en) | 2006-09-12 | 2010-02-11 | Ucb Pharma, S.A. | 2 Amino-Pyrimidine Derivatives As H4 Receptor Antagonists, Processes For Preparing Them And Their Use In Pharmaceutical Compositions |
| US7985745B2 (en) | 2006-10-02 | 2011-07-26 | Abbott Laboratories | Method for pain treatment |
| TW200904437A (en) | 2007-02-14 | 2009-02-01 | Janssen Pharmaceutica Nv | 2-aminopyrimidine modulators of the histamine H4 receptor |
| PE20091035A1 (es) * | 2007-11-30 | 2009-07-16 | Palau Pharma Sa | Derivados de 2-aminopirimidina |
| WO2009077608A1 (en) | 2007-12-19 | 2009-06-25 | Palau Pharma, S. A. | 2 -aminopyrimidine derivatives as histamine h4 antagonists |
| US8431580B2 (en) * | 2007-12-21 | 2013-04-30 | Palau Pharma, S.A. | 4-aminopyrimidine derivatives as histamine H4 receptor antagonists |
-
2010
- 2010-12-22 MX MX2012007385A patent/MX345142B/es active IP Right Grant
- 2010-12-22 RU RU2012131223/04A patent/RU2573828C2/ru active
- 2010-12-22 JP JP2012545331A patent/JP5781537B2/ja not_active Expired - Fee Related
- 2010-12-22 PE PE2012000880A patent/PE20121505A1/es not_active Application Discontinuation
- 2010-12-22 TW TW099145246A patent/TWI487697B/zh active
- 2010-12-22 US US13/518,729 patent/US8901146B2/en active Active
- 2010-12-22 AR ARP100104921A patent/AR079725A1/es not_active Application Discontinuation
- 2010-12-22 BR BR112012017126A patent/BR112012017126A2/pt not_active Application Discontinuation
- 2010-12-22 WO PCT/EP2010/070562 patent/WO2011076878A1/en not_active Ceased
- 2010-12-22 UA UAA201207986A patent/UA107818C2/uk unknown
- 2010-12-22 AU AU2010334804A patent/AU2010334804B2/en active Active
- 2010-12-22 CN CN201080064585.3A patent/CN102803248B/zh active Active
- 2010-12-22 CA CA2785353A patent/CA2785353C/en active Active
- 2010-12-22 NZ NZ601021A patent/NZ601021A/en unknown
- 2010-12-22 EP EP10799037.6A patent/EP2516420B8/en active Active
- 2010-12-22 KR KR1020127019521A patent/KR101740085B1/ko active Active
-
2012
- 2012-06-21 IL IL220554A patent/IL220554A/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015514060A5 (enExample) | ||
| JP2013537203A5 (enExample) | ||
| JP2017514910A5 (enExample) | ||
| JP2016506935A5 (enExample) | ||
| JP2020502092A5 (enExample) | ||
| JP2018502912A5 (enExample) | ||
| JP2014521688A5 (enExample) | ||
| JP2011132222A5 (enExample) | ||
| JP2014510727A5 (enExample) | ||
| JP2013502430A5 (enExample) | ||
| JP2016525102A5 (enExample) | ||
| JP2019535723A5 (enExample) | ||
| JP2014520898A5 (enExample) | ||
| JP2013063968A5 (enExample) | ||
| JP2015508092A5 (enExample) | ||
| EA201291236A1 (ru) | Азотные гетероциклические соединения, применимые в качестве ингибиторов pde10 | |
| JP2014501766A5 (enExample) | ||
| JP2016536286A5 (enExample) | ||
| JP2011528658A5 (enExample) | ||
| JP2015522589A5 (enExample) | ||
| JP2017517512A5 (enExample) | ||
| JP2016516043A5 (enExample) | ||
| WO2012018534A3 (en) | Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases | |
| JP2012513416A5 (enExample) | ||
| JP2016531126A5 (enExample) |